| Date Filed | Type | Description |
| 12/13/2017 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 15,731 shares
@ $0 |
|
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2016 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Converted 13,925 shares
@ $0
Converted 13,925 preferred shares
@ $0 |
|
| 03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/11/2015 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Converted 3,519 shares
@ $0
Converted 1,954 preferred shares
@ $0
Converted 1,565 preferred shares
@ $0 |
|
| 08/07/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Converted 17,000 shares
@ $0
Converted 8,792 preferred shares
@ $0
Converted 7,043 preferred shares
@ $0
Converted 1,165 preferred shares
@ $0 |
|
| 05/05/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Converted 9,208 shares
@ $0
Converted 3,882 preferred shares
@ $0 |
|
| 03/21/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on CADENCE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 78,369 shares
@ $14, valued at
$1.1M
|
|
| 01/17/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Sold 1,010 shares
@ $6.01, valued at
$6.1k
Sold 2,230 shares
@ $6.56, valued at
$14.6k
|
|
| 08/28/2013 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Converted 4,233 shares
@ $0
Converted 2,899 shares
@ $0
Converted 7,407 shares
@ $0
Converted 4,233 preferred shares
@ $0
Converted 2,899 preferred shares
@ $0
Converted 7,407 preferred shares
@ $0 |
|
| 07/16/2013 |
3
| DP VI Associates, L.P. (10% Owner) has filed a Form 3 on Ocera Therapeutics, Inc. |
| 06/24/2013 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Sold 114 shares
@ $5.01, valued at
$571.1 |
|
| 06/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2013 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Sold 425 shares
@ $5.03, valued at
$2.1k
Sold 959 shares
@ $5.4, valued at
$5.2k
|
|
| 03/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/15/2013 |
3
| DP VI Associates, L.P. (10% Owner) has filed a Form 3 on Celator Pharmaceuticals Inc |
| 12/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/21/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |